North East and North Cumbria
ICS Formulary
ICS Formulary
7 Obstetrics, Gynaecology, and urinary-tract disorders
07-04-02 Nocturnal enuresis
Green plus for the treatment of nocturnal enuresis in children aged 6 years and above when organic pathology, including spina bifida and related disorders, have been excluded and no response has been achieved to all other non-drug and drug treatments, including antispasmodics and vasopressin-related products.Should only be prescribed by a healthcare professional with expertise in the management of persistent enuresis
unlicensed.Links
County Durham and Darlington Adult Bladder and Bowel formulary First Line Prescribing Guide 2023- MHRA Drug Safety Update (Oct 2015): Mirabegron - risk of severe hypertension and associated cerebrovascular and cardiac events
- MHRA Drug Safety Update (Sep 2022): Methylphenidate long-acting (modified-release) preparations: caution if switching between products due to differences in formulations
- NICE NG118: Renal and ureteric stones: assessment and management
- NICE NG123: Urinary incontinence and pelvic organ prolapse in women: management
- NICE NG123: Urinary incontinence and pelvic organ prolapse in women: management
- NICE NG126: Ectopic pregnancy and miscarriage: diagnosis and initial management
- NICE NG210: Pelvic floor dysfunction: prevention and non-surgical management
- NICE TA290: Mirabegron for overactive bladder
- NICE TA999: Vibegron for treating symptoms of overactive bladder syndrome
North of Tyne, Gateshead and North Cumbria - Non-Surgical Management of Overactive Bladder (OAB)- North of Tyne, Gateshead and North Cumbria Urinary Continence Enablement Products and Devices Formulary Guideline (October 2024)
- North of Tyne, Gateshead and North Cumbria: Giggle Incontinence in children & young people aged 8 to 18 years
- NTAG recommendation on Vaginal devices for female urinary stress incontinence
- NTAG: Vaginal devices for female urinary stress incontinence
- Tees Urinary Continence Formulary February 2020